Big tobacco is making more appearances at scientific conferences focused on nonanimal toxicology testing. Representatives from tobacco giants—British American Tobacco, Japan Tobacco, Philip Morris International, and Reynolds American—participated in the annual meetingof the American Society for Cellular & Computational Toxicology (ASCCT) in September.
Their ultimate goal: to convince officials at the U.S. Food & Drug Administration’s Center for Tobacco Products (CTP) that in vitro methods for predicting respiratory toxicology in humans are ready for prime time.
CONTINUE ON www.cen.acs.org